AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GLOBAL X MORNINGSTAR GLOBAL

119.050

-0.680-0.57%

Volume:3K

Turnover:342.80K

Market Cap:344.30M

PE:- -

High:119.350

Open:118.900

Low:118.900

Close:119.730

52wk High:124.750

52wk Low:78.204

Shares:2.89M

Float Shares:2.89M

Volume Ratio:1.08

T/O Rate:0.10%

Dividend:3.83

Dividend Rate:3.22%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Bio-Techne (TECH): Do Steady Dividends Amid Soft Sales Reveal Its True Capital Allocation Priorities?

Simply Wall St.

Global X Units on Issue - April 2026

Assessing Bio-Techne (TECH) Valuation After Mixed Long Term Shareholder Returns

Simply Wall St.

Global X Units on Issue - March 2026

How Bio-Techne's Spatial Biology COMET Expansion (TECH) Has Changed Its Investment Story

Simply Wall St.

Bio-Techne’s New COMET Spatial Tools Might Change The Case For Investing In Bio-Techne (TECH)

Simply Wall St.

PDS dated 17 March 2026

ASX ETFs that target undervalued sectors

Bio‑Techne (TECH) Valuation Check After Earnings Beat And Renewed Institutional Interest

Simply Wall St.

Half Year Accounts-TEC

Global X Units on Issue - February 2026

Will Bio-Techne (TECH) Turn Ella’s EU Clinical Clearance Into A Precision-Medicine Edge?

Simply Wall St.

Assessing Bio-Techne (TECH) Valuation After Earnings Beat And New 3D Research Tool Launch

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TECH.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TECH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TECH.AU\",,,,,undefined,":{"symbol":"TECH.AU","market":"AU","secType":"STK","nameCN":"GLOBAL X MORNINGSTAR GLOBAL","latestPrice":119.05,"timestamp":1787292720000,"preClose":119.73,"halted":0,"volume":2876,"delay":0,"changeRate":-0.0056794454188591565,"nameEN":"GLOBAL X MORNINGSTAR GLOBAL","floatShares":2892067,"shares":2892067,"eps":0,"marketStatus":"Not Yet Opened","change":-0.68,"latestTime":"08-21 16:12:00 AEST","open":118.9,"high":119.35,"low":118.9,"amount":342804,"amplitude":0.003758,"askPrice":119.73,"askSize":2,"bidPrice":118.89,"bidSize":4,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":119.73,"sharesOutstanding":3198344,"nav":119.5893,"aum":343468509,"dividendRate":0.032183,"bidAskSpread":0,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":1.0816909233223455,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"TECH.AU","preClose":118.89,"auctionPrice":119.38,"auctionVolume":150,"auction":3,"marketStatus":"盘后竞价","timestamp":1787205615452}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TECH.AU\",,,,,undefined,":{"symbol":"TECH.AU","floatShares":2892067,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0816909233223455,"shares":2892067,"dividePrice":3.8314,"high":119.35,"amplitude":0.003758,"preClose":119.73,"low":118.9,"week52Low":78.204,"pbRate":"--","week52High":124.75,"institutionHeld":0,"latestPrice":119.05,"committee":0.333333,"eps":0,"divideRate":0.032183,"volume":2876,"delay":0,"ttmEps":0,"open":118.9,"prevYearClose":99.24,"prevWeekClose":124.58,"prevMonthClose":114.33,"prevQuarterClose":116.381,"fiveDayClose":124.58,"twentyDayClose":108.97,"sixtyDayClose":105.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TECH.AU\",params:#limit:5,,,undefined,":[{"date":"2026-07-02","symbol":"TECH.AU","amount":3.802321,"announcedDate":"2026-06-29","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-07-03","defaultRemindTime":1782950400000,"name":"GLOBAL X MORNINGSTAR GLOBAL","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-16","payableDate":"2026-07-03","currency":"AUD","dateTimestamp":1782914400000,"payDate":"2026-07-16"},{"date":"2025-06-30","symbol":"TECH.AU","amount":11.351401,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-07-01","defaultRemindTime":1751241600000,"name":"GLOBAL X MORNINGSTAR GLOBAL","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-16","payableDate":"2025-07-01","currency":"AUD","dateTimestamp":1751205600000,"payDate":"2025-07-16"},{"date":"2024-06-28","symbol":"TECH.AU","amount":5.514767,"announcedDate":"2024-06-24","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-07-01","defaultRemindTime":1719532800000,"name":"GLOBAL X MORNINGSTAR GLOBAL","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-16","payableDate":"2024-07-01","currency":"AUD","dateTimestamp":1719496800000,"payDate":"2024-07-16"},{"date":"2023-12-29","symbol":"TECH.AU","amount":0.0361091,"announcedDate":"2023-12-22","type":"dividend","market":"AU","newRecordDate":"2024-01-02","defaultRemindTime":1703804400000,"name":"ETFS Morningstar Global Technology ETF","recordDate":"2024-01-16","payableDate":"2024-01-02","currency":"AUD","dateTimestamp":1703768400000,"payDate":"2024-01-16"},{"date":"2023-06-30","symbol":"TECH.AU","amount":0.4572023,"announcedDate":"2023-06-26","type":"dividend","market":"AU","newRecordDate":"2023-07-03","defaultRemindTime":1688083200000,"name":"ETFS Morningstar Global Technology ETF","recordDate":"2023-07-17","payableDate":"2023-07-03","currency":"AUD","dateTimestamp":1688047200000,"payDate":"2023-07-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TECH.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-06-30","recordDate":"2021-07-01","paymentDate":"2021-07-15","value":14.656525,"currency":"AUD"},{"executeDate":"2022-06-30","recordDate":"2022-07-01","paymentDate":"2022-07-15","value":3.5497877,"currency":"AUD"},{"executeDate":"2023-06-30","recordDate":"2023-07-03","paymentDate":"2023-07-17","value":0.4572023,"currency":"AUD"},{"executeDate":"2023-12-29","recordDate":"2024-01-02","paymentDate":"2024-01-16","value":0.0361091,"currency":"AUD"},{"executeDate":"2024-06-28","recordDate":"2024-07-01","paymentDate":"2024-07-16","value":5.514767,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TECH.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2634741649","title":"Bio-Techne (TECH): Do Steady Dividends Amid Soft Sales Reveal Its True Capital Allocation Priorities?","url":"https://stock-news.laohu8.com/highlight/detail?id=2634741649","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634741649?lang=en_us&edition=fundamental","pubTime":"2026-05-09 22:33","pubTimestamp":1778337186,"startTime":"0","endTime":"0","summary":"Bio-Techne Corporation reported its fiscal third-quarter 2026 results in early May, with net sales of US$311.42 million, a 2% year-over-year decline, while net income rose to US$51.05 million and diluted EPS from continuing operations increased to US$0.32.\nAlongside softer demand from emerging biotech customers and shipment timing issues that weighed on revenue, Bio-Techne’s profitability improved and the Board affirmed a quarterly cash dividend of US$0.08 per share, highlighting an ongoing...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/bio-techne-tech-do-steady-dividends-amid-soft-sales-reveal-i","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/bio-techne-tech-do-steady-dividends-amid-soft-sales-reveal-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TECH","TECH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633115346","title":"Global X Units on Issue - April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633115346","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633115346?lang=en_us&edition=fundamental","pubTime":"2026-05-07 15:50","pubTimestamp":1778140231,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260507:nASXbZLHNG","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nASXbTqSJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GMTL.AU","DRGN.AU","FHNG.AU","FANG.AU","SEMI.AU","TECH.AU","GARP.AU","HGEN.AU","USTB.AU","USIG.AU","USHY.AU","ZYUS.AU","AINF.AU","BUGG.AU","PAVE.AU","GXAI.AU","ACDC.AU","WIRE.AU","LNAS.AU","UYLD.AU","BCOM.AU","HMND.AU","NDIA.AU","AYLD.AU","BANK.AU","ZYAU.AU","BK7054","RSSL.AU","SLVM.AU","GXLD.AU","OZXX.AU","J100.AU","ROBO.AU","SNAS.AU","U100.AU","GRPA.AU","DTEC.AU","QYLD.AU","ESTX.AU","GHLD.AU","A300.AU","GOLD.AU","CURE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633125928","title":"Assessing Bio-Techne (TECH) Valuation After Mixed Long Term Shareholder Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2633125928","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633125928?lang=en_us&edition=fundamental","pubTime":"2026-05-06 01:57","pubTimestamp":1778003820,"startTime":"0","endTime":"0","summary":"Bio-Techne stock: recent performance snapshot\nBio-Techne (TECH) has drawn investor attention after a mixed stretch, with a small gain over the past month alongside a decline over the past 3 months and weaker multi year total returns.\nAgainst that backdrop, the stock last closed at US$54.74, with annual revenue of US$1.22b and net income of US$81.06m. This positions the company as a mid cap player in life science tools and diagnostics.\nSee our latest analysis for Bio-Techne.\nShort term...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/assessing-bio-techne-tech-valuation-after-mixed-long-term-sh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/assessing-bio-techne-tech-valuation-after-mixed-long-term-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B19Z6F94.USD","IE0034390439.USD","BK4588","TECH","TECH.AU","LU2237957811.SGD","LU2237957902.USD","IE00B64QTZ34.USD","BK4585","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626976781","title":"Global X Units on Issue - March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626976781","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626976781?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:30","pubTimestamp":1775694655,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260409:nASX7nQ8fn","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nASX1bVFV1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["J100.AU","DRGN.AU","ESTX.AU","AINF.AU","FHNG.AU","TECH.AU","BANK.AU","DTEC.AU","GHLD.AU","WIRE.AU","U100.AU","BUGG.AU","USHY.AU","BCOM.AU","RSSL.AU","FANG.AU","SNAS.AU","ROBO.AU","SEMI.AU","GARP.AU","UYLD.AU","OZXX.AU","GXAI.AU","ACDC.AU","BK7054","GXLD.AU","USIG.AU","ZYAU.AU","PAVE.AU","GOLD.AU","ZYUS.AU","CURE.AU","GMTL.AU","NDIA.AU","USTB.AU","AYLD.AU","LNAS.AU","A300.AU","SLVM.AU","GRPA.AU","QYLD.AU","HGEN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625952795","title":"How Bio-Techne's Spatial Biology COMET Expansion (TECH) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2625952795","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625952795?lang=en_us&edition=fundamental","pubTime":"2026-04-07 23:20","pubTimestamp":1775575242,"startTime":"0","endTime":"0","summary":"In March 2026, Bio-Techne expanded its COMET spatial biology portfolio with new SPYRE Focus Panels, SPYRE Amplification Kits, and upgraded HORIZON image analysis software to enhance automated, modular tissue analysis workflows from assay design through interpretation.\nThis expansion deepens Bio-Techne’s footprint in high-content spatial biology by combining validated, modular antibody panels with seqLA-based signal amplification to help researchers extract richer insights from scarce tissue...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/how-bio-technes-spatial-biology-comet-expansion-tech-has-cha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/how-bio-technes-spatial-biology-comet-expansion-tech-has-cha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE0034390439.USD","IE00B64QTZ34.USD","TECH","BK4588","BK4121","TECH.AU","IE00B19Z6F94.USD","BK4585","LU2237957902.USD","LU2237957811.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623309968","title":"Bio-Techne’s New COMET Spatial Tools Might Change The Case For Investing In Bio-Techne (TECH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623309968","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623309968?lang=en_us&edition=fundamental","pubTime":"2026-03-31 13:07","pubTimestamp":1774933669,"startTime":"0","endTime":"0","summary":"In March 2026, Bio-Techne Corporation expanded its COMET spatial biology portfolio by introducing new SPYRE Focus Panels, SPYRE Amplification Kits using seqLA technology, and upgraded HORIZON Image Analysis Software to enhance automated, high-plex tissue analysis from assay design through interpretation.\nAn interesting aspect is how the modular SPYRE antibody panels and amplification tools are designed to plug into existing lab workflows, potentially shortening optimization timelines while...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/bio-technes-new-comet-spatial-tools-might-change-the-case-fo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/bio-technes-new-comet-spatial-tools-might-change-the-case-fo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TECH","TECH.AU","BK4588","BK4121","IE00B19Z6F94.USD","LU2237957811.SGD","IE0034390439.USD","IE00B64QTZ34.USD","LU2237957902.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620448052","title":"PDS dated 17 March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620448052","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620448052?lang=en_us&edition=fundamental","pubTime":"2026-03-17 13:37","pubTimestamp":1773725830,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260317:nASX9m3cPp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nASX5cmvRl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["U100.AU","GMTL.AU","FANG.AU","ZYUS.AU","GRPA.AU","SLVM.AU","ZYAU.AU","PAVE.AU","NDIA.AU","A300.AU","GXAI.AU","ROBO.AU","OZXX.AU","SEMI.AU","TECH.AU","ESTX.AU","ACDC.AU","CURE.AU","DRGN.AU","BUGG.AU","HGEN.AU","AINF.AU","GARP.AU","J100.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620497091","title":"ASX ETFs that target undervalued sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=2620497091","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620497091?lang=en_us&edition=fundamental","pubTime":"2026-03-17 06:36","pubTimestamp":1773700583,"startTime":"0","endTime":"0","summary":"One of the emerging stories this year has been the negative sentiment around healthcare and technology shares. Global technology shares have suffered due to AI integration and replacement fears. Meanw","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/17/asx-etfs-that-target-undervalued-sectors/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/17/asx-etfs-that-target-undervalued-sectors/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4585","BK4588","IXJ.AU","FDN","DRUG.AU","TECH.AU","BK4550","ATEC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620953495","title":"Bio‑Techne (TECH) Valuation Check After Earnings Beat And Renewed Institutional Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2620953495","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620953495?lang=en_us&edition=fundamental","pubTime":"2026-03-17 01:18","pubTimestamp":1773681497,"startTime":"0","endTime":"0","summary":"Recent quarterly results from Bio-Techne (TECH) came in ahead of earnings and revenue forecasts, and were followed by fresh institutional buying and portfolio additions that put renewed attention on the life sciences supplier.\nSee our latest analysis for Bio-Techne.\nDespite the upbeat quarter and renewed institutional interest, the 30 day share price return of a 15.15% decline and 1 year total shareholder return of an 18.27% loss show momentum has been weak, with pressure building across both...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/biotechne-tech-valuation-check-after-earnings-beat-and-renew","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/biotechne-tech-valuation-check-after-earnings-beat-and-renew","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TECH","TECH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619166386","title":"Half Year Accounts-TEC","url":"https://stock-news.laohu8.com/highlight/detail?id=2619166386","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619166386?lang=en_us&edition=fundamental","pubTime":"2026-03-13 14:30","pubTimestamp":1773383423,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260313:nASXl2NCx","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nASX7JTN57:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617507605","title":"Global X Units on Issue - February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2617507605","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617507605?lang=en_us&edition=fundamental","pubTime":"2026-03-06 14:32","pubTimestamp":1772778725,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260306:nASXJfHwf","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nASXx0c9N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WIRE.AU","GXLD.AU","DRGN.AU","FHNG.AU","J100.AU","HGEN.AU","GOLD.AU","DTEC.AU","CURE.AU","USIG.AU","SLVM.AU","QYLD.AU","GHLD.AU","AINF.AU","BK7054","UYLD.AU","ZYAU.AU","BCOM.AU","SNAS.AU","BANK.AU","NDIA.AU","A300.AU","FANG.AU","U100.AU","GXAI.AU","USTB.AU","GRPA.AU","LNAS.AU","OZXX.AU","RSSL.AU","BUGG.AU","PAVE.AU","TECH.AU","GARP.AU","USHY.AU","SEMI.AU","ESTX.AU","ROBO.AU","ACDC.AU","ZYUS.AU","AYLD.AU","GMTL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612431265","title":"Will Bio-Techne (TECH) Turn Ella’s EU Clinical Clearance Into A Precision-Medicine Edge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2612431265","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612431265?lang=en_us&edition=fundamental","pubTime":"2026-02-17 12:43","pubTimestamp":1771303383,"startTime":"0","endTime":"0","summary":"Bio-Techne recently announced that its Ella benchtop immunoassay platform has received CE-IVD marking and is now available for clinical use across the European Union, enabling faster, standardized biomarker testing with minimal hands-on time.\nThis certification broadens Ella’s role from research-only applications into regulated clinical workflows, potentially deepening Bio-Techne’s presence in precision medicine and hospital laboratory settings.\nWe’ll now examine how Ella’s CE-IVD clearance,...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/will-bio-techne-tech-turn-ellas-eu-clinical-clearance-into-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/will-bio-techne-tech-turn-ellas-eu-clinical-clearance-into-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B64QTZ34.USD","TECH","BK4121","EU","BK4156","IE0034390439.USD","BK4585","IE00B19Z6F94.USD","BK4588","TECH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611754101","title":"Assessing Bio-Techne (TECH) Valuation After Earnings Beat And New 3D Research Tool Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2611754101","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611754101?lang=en_us&edition=fundamental","pubTime":"2026-02-16 04:17","pubTimestamp":1771186666,"startTime":"0","endTime":"0","summary":"Why Bio-Techne Is Back on Investor Radar\nBio-Techne (TECH) has drawn fresh attention after quarterly results topped Wall Street expectations, supported by large pharmaceutical customers, tighter cost control and new product momentum in 3D stem cell and organoid research tools.\nSee our latest analysis for Bio-Techne.\nThose earnings and product updates have landed against a mixed share price backdrop, with a 12.73% 1 month share price decline and an 8.58% 1 year total shareholder return...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/assessing-bio-techne-tech-valuation-after-earnings-beat-and-1","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/assessing-bio-techne-tech-valuation-after-earnings-beat-and-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TECH","TECH.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":33,"code":"91000000","status":"200"}]}}